Edition:
United Kingdom

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

2.49USD
21 May 2018
Change (% chg)

$-0.11 (-4.23%)
Prev Close
$2.60
Open
$2.50
Day's High
$2.51
Day's Low
$2.48
Volume
2,083
Avg. Vol
8,340
52-wk High
$5.25
52-wk Low
$2.37

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.215
Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
FY 2016 Dec '16 0.00 -0.608
Sep '16 0.00 -0.530
Jun '16 0.00 -0.392
Mar '16 0.00 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.16 -0.16 -0.16 --
Quarter Ending Sep-18 1 -0.17 -0.17 -0.17 --
Year Ending Dec-18 1 -0.69 -0.69 -0.69 -0.46
Year Ending Dec-19 1 -0.64 -0.64 -0.64 -0.41
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.57 32.53
P/E High - Last 5 Yrs. -- 41.44 47.11
P/E Low - Last 5 Yrs. -- 23.40 24.61
Beta -- 0.80 0.79
Price to Sales (TTM) -- 4.06 8.85
Price to Book (MRQ) 18.86 3.49 4.22
Price to Tangible Book (MRQ) -- 4.40 5.79
Price to Cash Flow (TTM) -- 19.79 21.98
% Owned Institutions 3.37 1.27 2.39

Dividends

  Company industry sector
Dividend Yield -- 1.80 1.67
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.12
Payout Ratio(TTM) -- 16.85 17.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.97 5.06
Sales (TTM) vs TTM 1 Yr. Ago -- 10.12 12.43
Sales - 5 Yr. Growth Rate -- 7.45 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 64.71 37.00 32.52
EPS (TTM) vs TTM 1 Yr. Ago 39.52 -- --
EPS - 5 Yr. Growth Rate -- 7.09 8.54
Capital Spending - 5 Yr. Growth Rate -- 8.30 8.79

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.50
Current Ratio (MRQ) 0.79 3.58 3.56
LT Debt to Equity (MRQ) 0.00 10.34 12.76
Total Debt to Equity (MRQ) 25.08 12.69 15.69
Interest Coverage (TTM) -1.18 40.07 34.90

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.56 54.71
Gross Margin - 5 Yr. Avg. -- 52.71 52.74
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.51 15.91
Operating Margin (TTM) -- 13.07 -1.83
Operating Margin - 5 Yr. Avg. -- 14.25 11.18
Pre-Tax Margin (TTM) -- 13.35 0.25
Pre-Tax Margin - 5 Yr. Avg. -- 14.52 11.38
Net Profit Margin (TTM) -- 9.76 -3.16
Net Profit Margin - 5 Yr. Avg. -- 10.80 7.67
Effective Tax Rate (TTM) -- 22.46 31.64
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.59

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 836,134,495 726,901,196
Net Income/Employee (TTM) -- 97,299,163 84,519,443
Receivable Turnover (TTM) -- 5.53 5.67
Inventory Turnover (TTM) -- 2.49 3.53
Asset Turnover (TTM) 0.00 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -181.41 10.46 9.99
Return on Assets - 5 Yr. Avg. -- 11.69 11.11
Return on Investment (TTM) -299.35 13.08 12.63
Return on Investment - 5 Yr. Avg. -- 15.12 14.39
Return on Equity (TTM) -455.37 14.80 14.50
Return on Equity - 5 Yr. Avg. -- 16.36 15.75
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 53.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.30%
# of Holders: 16
Total Shares Held: 1,894,653
3 Mo. Net Change: 988,610
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 5
# Reduced Positions: 5
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.